Merck to buy UK’s Verona Pharma for $10 billion
US drugmaker Merck said on Wednesday it will buy UK-based Verona Pharma for about $10 billion. The acquisition will strengthen Merck’s respiratory treatments as part of efforts to reduce dependence on its blockbuster cancer treatment. Keytruda, the world…